Nishinomiya, Japan

Masashi Shiota

This inventor holds 4 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1980-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masashi Shiota. Retrieved from https://idiyas.com/inventor/masashi-shiota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 39(Granted Patents)


Location History:

  • Nishinomiya, JP (1980 - 1982)
  • Osaka, JP (1999)

Company Filing History:


Years Active: 1980-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Masashi Shiota

Introduction

Masashi Shiota is a prominent inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on innovative solutions that address various medical challenges.

Latest Patents

Among his latest patents are granules containing pranlukast and a process for producing these granules. Additionally, he has developed guanidinobenzoic acid derivatives, which exhibit anti-plasmin and anti-trypsin activities. These derivatives are characterized by a specific general formula that includes various alkyl and heterocyclic groups, showcasing his expertise in chemical innovation.

Career Highlights

Masashi Shiota is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Tsuyoshi Watanabe and Naohiro Kayama, contributing to a dynamic research environment that fosters innovation.

Conclusion

Masashi Shiota's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…